Rowatinex®
Rova
1977 Items
2019-09-19
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Rowatinex promotes disintegration and removal of kidney stones and urinary tract stones. Terpenes, such as Borneol, undergo metabolic changes and are excreted in the urine, mainly in the form of glucuronides, which increases the solubility of calcium salts (the main components of kidney stones and urinary tract stones). In a number of animal experiments, the inhibitory effect of Rowatinex on the formation of kidney stones and urinary tract stones was established.
Rowatinex has an antispasmodic effect, promotes the passage of stones through the urinary tract, reduces pain during renal and ureteral colic, increases renal blood flow, improving their function and increasing diuresis. It has anti-inflammatory action, antimicrobial action (in relation to a number of "gram-positive and gram-negative microorganisms), increases the content of protective colloids in the urine and increases the content of glucuronic acid in the urine.
Indications
Urolithiasis (nephrolithiasis, urolithiasis).
Prevention of kidney and urinary tract stones.
Composition
1 capsule contains: pinene [α + β] 31.0 mg, camphene 15.0 mg, cyneol 3.0 mg, fenchon 4.0 mg, borneol 10.0 mg, anethole 4.0 mg.
Excipients: olive oil
No customer reviews for the moment.
Dosage and Administration
Rowatinex is taken orally before meals.
For adults and children over 14 years old: Unless otherwise indicated by a doctor, the usual dose is 1-2 capsules three times daily before meals. In the case of renal colic, 2-3 capsules four to five times a day.
For children 6-14 years old: The usual dose is 1 capsule twice a day before meals.
Adverse reactions
A small number of patients noted mild and transient discomfort in the stomach.
Very rarely vomiting.
In two cases, drug intolerance was observed (cause unknown).
Contraindications
Hypersensitivity to the drug.
Children's age up to b years.
Drug interactions
Care must be taken when using the drug in patients taking inside anticoagulants or other drugs that undergo metabolism in the liver, if necessary, accurate dosing.
Special instructions
Rowatinex is not recommended for use in patients with severe renal colic, anuria, or severe urinary tract infection. In the process of treatment should increase fluid intake.
Overdosage
Treatment: if the drug is taken recently, it is necessary to flush the stomach, you should monitor the patient, using symptomatic treatment if necessary. It is recommended to monitor heart, respiratory, renal and hepatic functions.
- Brand name: Rowatinex
- High temperature reduces apple fruit colour via modulation of the anthocyanin regulatory complex
- Responses of mammal dispersers to fruit availability: Rowan (Sorbus aucuparia) and carnivores in mountain habitats of northern Spain
- Handbook of Proteolytic Enzymes || Fruit Bromelain
- The Climacteric in Ripening Tomato Fruit
- Changes in Adenosine Pyrophosphates in Cantaloupe Fruit Ripening Normally and after Treatment with Ethylene
- Volatile Constituents of Ripe Boysenberry Fruit
- The Climacteric in Ripening Tomato Fruit
- Masting and Trophic Cascades: Interplay between Rowan Trees, Apple Fruit Moth, and Their Parasitoid in Southern Norway
- COMPARISON OF FRUIT CULTIVAR 'MORAVSKY SLADKOPLODY' BELONGING TO THE SPECIES SORBUS AUCUPARIA L. WITH OTHER ROWAN CULTIVARS, INTERSPECIFIC HYBRIDS AND WILD ROWAN
- Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study
8 other products in the same category:
arrow_upward